Toroso Investments LLC Buys 641 Shares of Agilent Technologies, Inc. (NYSE:A)

Toroso Investments LLC lifted its position in Agilent Technologies, Inc. (NYSE:A) by 9.3% during the 1st quarter, according to the company in its most recent filing with the SEC. The fund owned 7,544 shares of the medical research company’s stock after purchasing an additional 641 shares during the quarter. Toroso Investments LLC’s holdings in Agilent Technologies were worth $1,042,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in the company. Delta Asset Management LLC TN bought a new stake in shares of Agilent Technologies during the fourth quarter valued at approximately $26,000. Money Concepts Capital Corp acquired a new stake in shares of Agilent Technologies in the 4th quarter valued at $26,000. Ancora Advisors LLC bought a new stake in shares of Agilent Technologies during the fourth quarter worth $34,000. Stone House Investment Management LLC acquired a new position in shares of Agilent Technologies during the first quarter valued at $36,000. Finally, Thompson Siegel & Walmsley LLC acquired a new stake in Agilent Technologies in the fourth quarter worth about $39,000.

Insider Transactions at Agilent Technologies

In other Agilent Technologies news, CEO Michael R. Mcmullen sold 944 shares of the company’s stock in a transaction dated Thursday, July 27th. The stock was sold at an average price of $130.00, for a total value of $122,720.00. Following the sale, the chief executive officer now owns 260,869 shares in the company, valued at approximately $33,912,970. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In other news, VP Rodney Gonsalves sold 3,500 shares of the business’s stock in a transaction dated Wednesday, August 23rd. The shares were sold at an average price of $118.78, for a total transaction of $415,730.00. Following the completion of the sale, the vice president now directly owns 24,219 shares of the company’s stock, valued at $2,876,732.82. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CEO Michael R. Mcmullen sold 944 shares of the firm’s stock in a transaction dated Thursday, July 27th. The shares were sold at an average price of $130.00, for a total transaction of $122,720.00. Following the completion of the transaction, the chief executive officer now directly owns 260,869 shares in the company, valued at approximately $33,912,970. The disclosure for this sale can be found here.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on A. Jefferies Financial Group cut their price target on shares of Agilent Technologies from $150.00 to $146.00 and set a “buy” rating on the stock in a research report on Wednesday, August 16th. 888 restated a “maintains” rating on shares of Agilent Technologies in a research report on Wednesday, May 24th. SVB Securities reduced their target price on Agilent Technologies from $170.00 to $145.00 and set an “outperform” rating on the stock in a report on Wednesday, May 24th. Credit Suisse Group lowered their price target on Agilent Technologies from $160.00 to $150.00 and set an “outperform” rating for the company in a report on Wednesday, August 16th. Finally, Citigroup cut their price objective on Agilent Technologies from $150.00 to $130.00 and set a “neutral” rating on the stock in a report on Wednesday, May 24th. One research analyst has rated the stock with a sell rating, three have assigned a hold rating and twelve have issued a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $148.12.

Agilent Technologies Trading Down 2.8 %

Shares of A stock opened at $112.67 on Tuesday. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.68 and a current ratio of 2.29. Agilent Technologies, Inc. has a fifty-two week low of $109.00 and a fifty-two week high of $160.26. The company has a market cap of $32.97 billion, a PE ratio of 29.49, a P/E/G ratio of 2.12 and a beta of 1.03. The stock’s fifty day moving average price is $121.61 and its two-hundred day moving average price is $126.47.

Agilent Technologies (NYSE:A) last announced its quarterly earnings results on Tuesday, August 15th. The medical research company reported $1.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.36 by $0.07. Agilent Technologies had a net margin of 16.20% and a return on equity of 29.86%. The company had revenue of $1.67 billion for the quarter, compared to analyst estimates of $1.66 billion. During the same period in the previous year, the firm posted $1.34 EPS. The firm’s revenue was down 2.7% on a year-over-year basis. Equities analysts predict that Agilent Technologies, Inc. will post 5.42 EPS for the current fiscal year.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies.